The American Society of Plastic Surgeons has become the first major American medical association to express opposition to the controversial view that surgical interventions are appropriate for minors diagnosed with gender dysphoria.

The news emerged in a new report from Manhattan Institute fellow and pediatric gender medicine expert Leor Sapir.

Sapir revealed that ASPS, which represents the vast majority plastic surgeons in the U.S., has broken with the U.S. official medical consensus of support for transgender medicine for minors.

“The American Society of Plastic Surgeons, an organization representing 92% of all board-certified plastic surgeons in the U.S., becomes the first major medical association to break from the consensus over “gender-affirming care” for minors,” said Sapir on X.

Sapir reached out to the ASPS for comment last month, soliciting their opinion on the leaked internal documents from the World Professional Association for Transgender Health (WPATH), which sets the guidelines for transgender care for minors in the U.S., showing that the organization consistently violated medical ethics and based its medical recommendations on a forged consensus.

Sapir found that the ASPS does not accept the guidelines from either WPATH or any other organization on transgender medicine for minors and recognized that there is no clear evidence that transgender surgeries provide any long-term benefits to minors.

The rebuke to the WPATH standards is significant because, in many states, including Maine, Medicaid reimbursement practices have been crafted according to WPATH recommendations.

The organization also acknowledged that the evidence provided in favor of transgender medicine for minors is “low evidence” and “low quality.”

ASPS stopped short of condemning transgender procedures and medication for minors, but its refusal to accept the existing, extremely permissive rules shows that the U.S. medical establishment is less united in support of child genital mutilation than WPATH or supporters of radical gender ideology wish to claim.

Sapir believes that the ASPS is likely working to provide its own guidelines for its members, some of whom have faced lawsuits from detransitioners who received surgeries as minors that they now regret.

One plastic surgeon at Kaiser Permanente faces a lawsuit from a girl on whom he performed a double mastectomy when she was only 13.

Despite ASPS’s dissent, the U.S. remains one of the most extremely permissive countries in the world for transgender medicine, where minors are routinely able to receive double mastectomies, puberty blockers, and cross-sex hormones, and in some cases, genital mutilating surgeries.

Recently, Europe has begun to step away from transgender medicine for minors.

Even the U.K., which is controlled by the far-left Labour Party, has decided to stop almost all use of puberty blockers for minors after studies revealed that the drugs cause permanent harm to bone development.